Résumé
Le carcinome épidermoïde du pénis est une tumeur peu fréquente. La classification selon le système TNM 2009 nécessite un examen physique précis, parfois aidé par l’imagerie. L’examen physique permet d’évaluer la morphologie et les caractéristiques de la tumeur, en particulier doit rechercher une infiltration de l’albuginée des corps caverneux et/ou un envahissement de l’urètre. Ce n’est qu’en cas d’insuffisance de cet examen physique que l’échographie et surtout l’IRM pénienne, faite en érection, seront utiles en particulier pour les tumeurs du gland pour envisager un traitement conservateur. Si pour les tumeurs évoluées, les techniques d’amputation sont le traitement de référence, les tumeurs localisées au gland et au prépuce doivent impérativement bénéficier des techniques conservatrices chirurgicales ou radiothérapiques.
Abstract
Squamous cell carcinoma of the penis is a rare tumor. According to the TNM classification (UICC 2009), a precise physical examination, sometimes matched with imaging, is required for the staging of penile carcinoma. Physical examination of the primary tumor, which allows for an evaluation of the tumor’s morphology and physical characteristics, is essential in particular, in order to detect an infiltration of albuginea of the corpus cavernosa and/or an invasion of the urethra. When physical examination appears to be insufficient, ultrasound and especially MRI with intracavernosal injection of prostaglandin E1 are useful, particularly in order to improve the selection of patients eligible for conservative treatment. When tumors have evolved, amputation techniques have proven to be the best option. However, tumors localized only on the glans and prepuce imperatively require the use of conservative techniques, either surgery or radiotherapy.
This is a preview of subscription content, log in via an institution to check access.
Références
Agrawal A, Pai D, Ananthakrishnan N, et al. (2000) Clinical and sonographic findings in carcinoma of the penis. J Clin Ultrasound 28: 399–406
Austoni E, Fenice O, Kartalas Goumas Y, et al. (1996) New trends in the surgical treatment of penile carcinoma. Arch Ital Urol Androl 68: 163–168
Chaux A, Cubilla AL (2012) Advances in the pathology of penile carcinomas. Hum Pathol 43: 771–789
Crook JM, Jezioranski J, Grimard L, et al. (2005) Penile brachytherapy: results for 49 patients. Int J Radiat Oncol Biol Phys 62: 460–467
de Crevoisier R, Slimane K, Sanfilippo N, et al. (2009) Longterm results of brachytherapy for carcinoma of the penis confined to the glans (N- or NX). Int J Radiat Oncol Biol Phys 74: 1150–1156
Goette DK, Elgart M, DeVillez RL (1975) Erythroplasia of Queyrat. Treatment with topically applied fluorouracil. JAMA 232: 934–937
Hoffman MA, Renshaw AA, Loughlin KR (1999) Squamous cell carcinoma of the penis and microscopic pathologic margins: how much margin is needed for local cure? Cancer 85: 1565–1568
Horenblas S, Van Tinteren H, Delemarre JF, et al. (1991) Squamous cell carcinoma of the penis: accuracy of tumor, nodes and metastasis classification system, and role of lymphangiography, computerized tomography scan and fine needle aspiration cytology. J Urol 146: 1279–1283
Horenblas S, Van Tinteren H (1994) Squamous cell carcinoma of the penis. IV. Prognostic factors of survival: analysis of tumor, nodes and metastasis classification system. J Urol 151: 1239–1243
Horenblas S, Kroger R, Gallee MP, et al. (1994) Ultrasound in squamous cell carcinoma of the penis; a useful addition to clinical staging? A comparison of ultrasound with histopathology. Urology 43: 702–707
Kayes O, Minhas S, Allen C, et al. (2007) The role of magnetic resonance imaging in the local staging of penile cancer. Eur Urol 51: 1313–1318
Leijte JA, Gallee M, Antonini N, et al. (2008) Evaluation of current TNM classification of penile carcinoma. J Urol 180: 933–938
Leijte JA, Kirrander P, Antonini N, et al. (2008) Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur Urol 54: 161–168
Longpre MJ, Lange PH, Kwon JS, et al. (2013) Penile carcinoma: lessons learned from vulvar carcinoma. J Urol 189: 17–24
Lont AP, Besnard AP, Gallee MP, et al. (2003) A comparison of physical examination and imaging in determining the extent of primary penile carcinoma. BJU Int 91: 493–495
Lont AP, Gallee MP, Meinhardt W, et al. (2006) Penis conserving treatment for T1 and T2 penile carcinoma: clinical implications of a local recurrence. J Urol 176: 575–580
Meijer RP, Boon TA, Van Venrooij GE, et al. (2007) Long-term follow-up after laser therapy for penile carcinoma. Urology 69: 759–762
Minhas S, Kayes O, Hegarty P, et al. (2005) What surgical resection margins are required to achieve oncological control in men with primary penile cancer? BJU Int 96: 1040–1043
Naumann CM, Filippow N, Seif C, et al. (2005) Penile carcinoma (pT1 G2): surveillance or inguinal lymph node dissection? Onkologie 28: 135–138
Philippou P, Shabbir M, Malone P, et al. (2012) Conservative surgery for squamous cell carcinoma of the penis: resection margins and long-term oncological control. J Urol 188: 803–808
Pietrzak P, Corbishley C, Watkin N (2004) Organ-sparing surgery for invasive penile cancer: early follow-up data. BJU Int 94: 1253–1257
Romero FR, Romero KR, Mattos MA (2005) Sexual function after partial penectomy for penile cancer. Urology 66: 1292–1295
Van Bezooijen BP, Horenblas S, Meinhardt W, et al. (2001) Laser therapy for carcinoma in situ of the penis. J Urol 166: 1670–1671
Velazquez EF, Barreto JE, Rodriguez I, et al. (2004) Limitations in the interpretation of biopsies in patients with penile squamous cell carcinoma. Int J Surg Pathol 12: 139–146
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Bouchot, O., Branchereau, J., Loubersac, T. et al. Le carcinome épidermoïde du pénis: évaluation clinique et thérapeutique de la tumeur primitive. Oncologie 16, 174–180 (2014). https://doi.org/10.1007/s10269-014-2380-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10269-014-2380-4